Pharmaceutical Production In Iran
President Akbar Hashemi Rafsanjani of Iran has said that the country's pharmaceutical production has increased fivefold since the revolution, and that surplus medicines are now being exported.
Over 17,000 types of medicines are available on the domestic market, and more than 95% of the population is covered by vaccination programs, according to the President. He paid tribute to health workers and pharmaceutical companies for their part in developing the country's health care sector, according to the IRNA news agency.
Meantime, Iranian health Minister Ali Akbar Velyati paid a visit to Vietnam in early April, during which the Vietnamese Heath Minister, Nguygen Manh Cam, said that his country is keen to establish joint ventures with Iran for the production and marketing of pharmaceuticals, say reports from IRNA.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze